Media Inquiries: or 1-844-723-7228

ALZpath News

Clinical Trials on Alzheimer Disease (CTAD)

DECEMBER 27, 2022

Plasma P-tau217 Picks up Plaques, Tangles, Future Decline

Press Release

NOVEMBER 11, 2022

“ALZpath, Inc.”, an Alzheimer’s Disease Diagnostics and Patient Services Company Announces Novel Validated an Scalable Assay for Detection of Phosphorylated Tau 217 in Blood

Alzheimer’s in the News

Lilly's Donanemab Significantly Slowed Cognitive and Functional Decline in Phase 3 Study of Early Alzheimer's Disease

Lilly Investors News Release: May 3, 2023

Catalyst: Hope is on the Horizon for Alzheimer’s Treatments

The Stanford GSB Experience: March 10, 2023

MIND and Mediterranean Diets Associated with fewer Alzheimer's Plaques and Tangles

American Academy of Neurology: March 8, 2023